Cargando…
Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
Glioblastoma multiforme (GBM) is the most common and lethal type of brain tumor, and the clinically available approaches for its treatment are not curative. Despite the intensive research, biological barriers such as the blood–brain barrier (BBB) and tumor cell membranes are major obstacles to devel...
Autores principales: | Ramalho, Maria João, Loureiro, Joana Angélica, Coelho, Manuel A. N., Pereira, Maria Carmo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880499/ https://www.ncbi.nlm.nih.gov/pubmed/35214012 http://dx.doi.org/10.3390/pharmaceutics14020279 |
Ejemplares similares
-
Transferrin-Conjugated
PLGA Nanoparticles for Co-Delivery
of Temozolomide and Bortezomib to Glioblastoma Cells
por: Ramalho, Maria João, et al.
Publicado: (2023) -
Immunoliposomes doubly targeted to transferrin receptor and to α-synuclein
por: Loureiro, Joana A, et al.
Publicado: (2015) -
Comparison of polypeptides that bind the transferrin receptor for targeting gold nanocarriers
por: McQuaid, Conor, et al.
Publicado: (2021) -
Factorial Design as a Tool for the Optimization of PLGA Nanoparticles for the Co-Delivery of Temozolomide and O6-Benzylguanine
por: Ramalho, Maria João, et al.
Publicado: (2019) -
Interaction of Bortezomib with Cell Membranes Regulates Its Toxicity and Resistance to Therapy
por: Ramalho, Maria João, et al.
Publicado: (2022)